Results 281 to 290 of about 287,893 (307)

Cadonilimab rechallenge in patients with recurrent or metastatic cervical cancer following prior PD-1/PD-L1 inhibitor failure: a retrospective multicenter study. [PDF]

Front Immunol
Yu H, Chen J, Lin J, Chen L, Zou J, Liu B, Liu L, Xie N, Deng S, Zhou S, Sun Y.   +10 more
europepmc   +1 more source

RIPK3 inhibitor GSK872 targets angiotensin II induced cardiomyocyte hypertrophy by regulating Ca2+/ calmodulin dependent protein kinase II. [PDF]

PLoS One
Zhang J, Yu H, Yang Y, Liu A, Wang P.
europepmc   +1 more source

Integrating machine learning and multi-omics analysis to explore Treg-associated programmed cell death features in clear cell renal cell carcinoma. [PDF]

Cancer Cell Int
Dai H, Zhang X, Yin L, Chen H, Liu K, Li J, Li H, Sheng L, Wu H, Wang J, He S, Li Q, Lv Y.   +12 more
europepmc   +1 more source

The mechanism and research progress of PD-1/PD-L1 on immune escape of lung cancer. [PDF]

Transl Cancer Res
Li Z, Wang T, Liu J, Qi W, Lv Q, Xu Y, Tian L.   +6 more
europepmc   +1 more source

The CCL11-CCR3 Axis Regulates the Aggravation of Neuroinflammation in Astrocytic Necroptosis After Cerebral Ischemia. [PDF]

FASEB J
Yin H, Zhang X, Li M, Liu Y, Zhang Y, Zhang Y, Ci H, Li K, Yang S, Wang G, Zhang T.   +10 more
europepmc   +1 more source

Programmed cell death protein-1 and other inhibitory receptors expressed by regulatory T cells as a restraining factor of checkpoint therapy

Е. В. Баторов, Aleksandr Ostanin, Е. Р. Черных   +2 more
openalex   +2 more sources

CAR-T therapy: Advances in respiratory diseases. [PDF]

Chin Med J Pulm Crit Care Med
Han H, Hu Y.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Ca-A Cancer Journal for Clinicians, 2021
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel   +2 more
exaly  

Cancer Statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Rebecca L Siegel, Kimberly D Miller
exaly  

Cancer statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal Dvm   +2 more
exaly